Fluorescent‐protein co‐expression to select CHO cells expressing high quantities of vaccine antigens

Abstract

AbstractCell line development for production of vaccine antigens or therapeutic proteins typically involves transfection, selection, and enrichment for high‐expressing cells. Enrichment methods include minipool enrichment, antibody‐based enrichment, and enrichment based on co‐expressed fluorescent biosensor proteins. However, these methods have limitations regarding labor and cost intensity, the generation of antibodies and assurance of their viral safety, and potential expression‐interference or signal‐saturation of the co‐expressed fluorescent protein. To improve the method of fluorescent‐protein co‐expression, expression constructs were created that constitutively express a model vaccine antigen together with one of three fluorescent proteins having translation initiation controlled by a wildtype or mutant internal ribosome entry site (IRES), for a total of six constructs. The constructs were transfected into Chinese hamster ovary cells (CHO) cells, enriched for high fluorescence, cultured, and tested in a mini bioreactor to identify the most promising construct. The fluorescent protein, Fluorescent Ubiquitination‐based Cell Cycle Indicator (FUCCI) with a mutant IRES performed best and was further tested with three additional vaccine antigens. Across the four vaccine antigens, the FUCCI fluorescent protein yielded productivity enhancements, without the need for generating an antibody and assuring its viral safety. Furthermore, FUCCI protein was present in negligible quantities in the cell supernatant, indicating a low risk for contaminating drug substances or vaccine antigen.